MX2016006252A - Tratamiento o prevencion de afecciones pulmonares con monoxido de carbono. - Google Patents
Tratamiento o prevencion de afecciones pulmonares con monoxido de carbono.Info
- Publication number
- MX2016006252A MX2016006252A MX2016006252A MX2016006252A MX2016006252A MX 2016006252 A MX2016006252 A MX 2016006252A MX 2016006252 A MX2016006252 A MX 2016006252A MX 2016006252 A MX2016006252 A MX 2016006252A MX 2016006252 A MX2016006252 A MX 2016006252A
- Authority
- MX
- Mexico
- Prior art keywords
- carbon monoxide
- patient
- haemoglobin
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Un método para tratar a un paciente que tiene una afección pulmonar que incluye identificar un nivel de hemoglobina-monóxido de carbono objetivo en la sangre del paciente. El método también incluye la administración al paciente de monóxido de carbono en una primera concentración durante un período de tiempo inicial y medir el nivel de hemoglobina-monóxido de carbono en la sangre del paciente. El método también incluye calcular, en función del nivel de hemoglobina-monóxido de carbono medido y el nivel de hemoglobina-monóxido de carbono objetivo, una dosis de monóxido de carbono necesaria para lograr el nivel de hemoglobina-monóxido de carbono objetivo dentro de un período de tiempo determinado. El método también incluye administrarle al paciente la dosis calculada de monóxido de carbono durante el período de tiempo determinado para obtener el nivel de hemoglobina-monóxido de carbono objetivo en la sangre del paciente.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361904047P | 2013-11-14 | 2013-11-14 | |
| US201461993137P | 2014-05-14 | 2014-05-14 | |
| PCT/US2014/065822 WO2015073912A1 (en) | 2013-11-14 | 2014-11-14 | Treatment or prevention of pulmonary conditions with carbon monoxide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016006252A true MX2016006252A (es) | 2017-02-02 |
Family
ID=53058110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016006252A MX2016006252A (es) | 2013-11-14 | 2014-11-14 | Tratamiento o prevencion de afecciones pulmonares con monoxido de carbono. |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20160256485A1 (es) |
| EP (1) | EP3068409A4 (es) |
| JP (1) | JP2016537427A (es) |
| MX (1) | MX2016006252A (es) |
| WO (1) | WO2015073912A1 (es) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11636870B2 (en) | 2020-08-20 | 2023-04-25 | Denso International America, Inc. | Smoking cessation systems and methods |
| US11760169B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Particulate control systems and methods for olfaction sensors |
| US11760170B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Olfaction sensor preservation systems and methods |
| US11813926B2 (en) | 2020-08-20 | 2023-11-14 | Denso International America, Inc. | Binding agent and olfaction sensor |
| US11828210B2 (en) | 2020-08-20 | 2023-11-28 | Denso International America, Inc. | Diagnostic systems and methods of vehicles using olfaction |
| US11881093B2 (en) | 2020-08-20 | 2024-01-23 | Denso International America, Inc. | Systems and methods for identifying smoking in vehicles |
| US11932080B2 (en) | 2020-08-20 | 2024-03-19 | Denso International America, Inc. | Diagnostic and recirculation control systems and methods |
| US12017506B2 (en) | 2020-08-20 | 2024-06-25 | Denso International America, Inc. | Passenger cabin air control systems and methods |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9900177B2 (en) | 2013-12-11 | 2018-02-20 | Echostar Technologies International Corporation | Maintaining up-to-date home automation models |
| US9769522B2 (en) | 2013-12-16 | 2017-09-19 | Echostar Technologies L.L.C. | Methods and systems for location specific operations |
| TW201618795A (zh) | 2014-04-15 | 2016-06-01 | 波泰里斯股份有限公司 | 用以改良器官功能及延長器官移植物壽命之系統及方法 |
| US9824578B2 (en) | 2014-09-03 | 2017-11-21 | Echostar Technologies International Corporation | Home automation control using context sensitive menus |
| EP3199098B1 (en) * | 2014-09-23 | 2024-02-07 | Shenzhen Seekya Bio-Sci & Tech Co., Ltd. | Method and apparatus for measuring endogenous co concentration in alveolar air |
| US9989507B2 (en) * | 2014-09-25 | 2018-06-05 | Echostar Technologies International Corporation | Detection and prevention of toxic gas |
| US9511259B2 (en) | 2014-10-30 | 2016-12-06 | Echostar Uk Holdings Limited | Fitness overlay and incorporation for home automation system |
| US9983011B2 (en) | 2014-10-30 | 2018-05-29 | Echostar Technologies International Corporation | Mapping and facilitating evacuation routes in emergency situations |
| US9967614B2 (en) | 2014-12-29 | 2018-05-08 | Echostar Technologies International Corporation | Alert suspension for home automation system |
| US9729989B2 (en) | 2015-03-27 | 2017-08-08 | Echostar Technologies L.L.C. | Home automation sound detection and positioning |
| US9948477B2 (en) | 2015-05-12 | 2018-04-17 | Echostar Technologies International Corporation | Home automation weather detection |
| US9946857B2 (en) | 2015-05-12 | 2018-04-17 | Echostar Technologies International Corporation | Restricted access for home automation system |
| US9960980B2 (en) | 2015-08-21 | 2018-05-01 | Echostar Technologies International Corporation | Location monitor and device cloning |
| US9996066B2 (en) | 2015-11-25 | 2018-06-12 | Echostar Technologies International Corporation | System and method for HVAC health monitoring using a television receiver |
| US10101717B2 (en) | 2015-12-15 | 2018-10-16 | Echostar Technologies International Corporation | Home automation data storage system and methods |
| US10091017B2 (en) | 2015-12-30 | 2018-10-02 | Echostar Technologies International Corporation | Personalized home automation control based on individualized profiling |
| US10073428B2 (en) | 2015-12-31 | 2018-09-11 | Echostar Technologies International Corporation | Methods and systems for control of home automation activity based on user characteristics |
| US10060644B2 (en) | 2015-12-31 | 2018-08-28 | Echostar Technologies International Corporation | Methods and systems for control of home automation activity based on user preferences |
| CN106124749B (zh) * | 2016-02-26 | 2019-01-29 | 深圳市先亚生物科技有限公司 | 一种红细胞寿命测定方法及装置 |
| US9882736B2 (en) | 2016-06-09 | 2018-01-30 | Echostar Technologies International Corporation | Remote sound generation for a home automation system |
| US10294600B2 (en) | 2016-08-05 | 2019-05-21 | Echostar Technologies International Corporation | Remote detection of washer/dryer operation/fault condition |
| US10049515B2 (en) | 2016-08-24 | 2018-08-14 | Echostar Technologies International Corporation | Trusted user identification and management for home automation systems |
| US20230201497A1 (en) * | 2020-05-29 | 2023-06-29 | Bellerophon Therapeutics | Method for pulsatile delivery of a gaseous drug |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10230165A1 (de) * | 2002-07-04 | 2004-01-15 | Ino Therapeutics Gmbh | Verfahren und Vorrichtung zur Administration von Kohlenmonoxid |
| US8778413B2 (en) * | 2010-05-14 | 2014-07-15 | Ikaria, Inc. | Dosing regimens and methods of treatment using carbon monoxide |
| JP6404208B2 (ja) * | 2012-03-27 | 2018-10-10 | ジェネンテック， インコーポレイテッド | 特発性肺線維症の予後予測、診断および処置の方法 |
-
2014
- 2014-11-14 JP JP2016554530A patent/JP2016537427A/ja active Pending
- 2014-11-14 MX MX2016006252A patent/MX2016006252A/es unknown
- 2014-11-14 EP EP14862973.6A patent/EP3068409A4/en not_active Withdrawn
- 2014-11-14 US US15/035,796 patent/US20160256485A1/en not_active Abandoned
- 2014-11-14 WO PCT/US2014/065822 patent/WO2015073912A1/en active Application Filing
-
2018
- 2018-09-26 US US16/142,883 patent/US20190022132A1/en not_active Abandoned
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11636870B2 (en) | 2020-08-20 | 2023-04-25 | Denso International America, Inc. | Smoking cessation systems and methods |
| US11760169B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Particulate control systems and methods for olfaction sensors |
| US11760170B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Olfaction sensor preservation systems and methods |
| US11813926B2 (en) | 2020-08-20 | 2023-11-14 | Denso International America, Inc. | Binding agent and olfaction sensor |
| US11828210B2 (en) | 2020-08-20 | 2023-11-28 | Denso International America, Inc. | Diagnostic systems and methods of vehicles using olfaction |
| US11881093B2 (en) | 2020-08-20 | 2024-01-23 | Denso International America, Inc. | Systems and methods for identifying smoking in vehicles |
| US11932080B2 (en) | 2020-08-20 | 2024-03-19 | Denso International America, Inc. | Diagnostic and recirculation control systems and methods |
| US12017506B2 (en) | 2020-08-20 | 2024-06-25 | Denso International America, Inc. | Passenger cabin air control systems and methods |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3068409A4 (en) | 2017-08-23 |
| EP3068409A1 (en) | 2016-09-21 |
| US20190022132A1 (en) | 2019-01-24 |
| WO2015073912A1 (en) | 2015-05-21 |
| US20160256485A1 (en) | 2016-09-08 |
| JP2016537427A (ja) | 2016-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016006252A (es) | Tratamiento o prevencion de afecciones pulmonares con monoxido de carbono. | |
| NZ630749A (en) | Real-time detection of periodic breathing | |
| MX2021010672A (es) | Uso de un anticuerpo que tiene la capacidad para ligarse a clnd6 en el tratamiento o prevención de cáncer. | |
| MX2020009903A (es) | Dispositivos y metodos para monitorizar la oxigenacion durante el tratamiento con el suminitro de oxido nitrico. | |
| MX2022007788A (es) | Sistema y metodo de monitoreo de inhalacion. | |
| MX343368B (es) | Metodo de diagnostico y tratamiento de cancer en pacientes que tienen o desarrollan resistencia a una primera terapia de cancer. | |
| MX2018000464A (es) | Procedimientos y composiciones para el diagnostico y para el tratamiento de adrenoleucodistrofia. | |
| WO2012174102A3 (en) | Methods and apparatus for guiding medical care based on detected gastric function | |
| NZ707064A (en) | Method and systems for the delivery of oxygen enriched gas | |
| GB2537574A (en) | Systems, methods and apparatuses for the alleviation and outcome monitoring of sleep disordered breathing | |
| MX2016009060A (es) | Metodos y sistemas para determinar el riesgo de falla cardiaca. | |
| MX2016002879A (es) | Sistemas, dispositivos y metodos para la terapia anti-tl1a. | |
| MX2017006242A (es) | Determinacion de niveles de glicosaminoglicanos mediante espectrometria de masas. | |
| MX2018004170A (es) | Biomarcadores relacionados con enfermedades mediadas por interleucina-33 (il-33) y usos de los mismos. | |
| MX2020001369A (es) | Sistema de analisis para el cuidado de un paciente. | |
| EA201700123A1 (ru) | Способ прогнозирования варианта лекарственного препарата для лечения депрессии | |
| MX2015012444A (es) | Metodos de diagnostico, seleccion y tratamiento de enfermedades y afecciones provocadas por o asociadas con metanogenos. | |
| MX2017003513A (es) | Formación de imágenes de inflamación e infección dirigida a hsp90 y terapia. | |
| MX2015009523A (es) | Control de suminstros de oxigeno neonatal. | |
| NZ716643A (en) | Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event | |
| WO2015174864A8 (en) | Methods and apparatus for flow therapy | |
| MX2015001788A (es) | Metabolitos de metionina predicen la evolución agresiva del cáncer. | |
| TN2015000315A1 (en) | Methods of treating cardiovascular indications | |
| WO2014126796A3 (en) | Methods of diagnosing, treating and monitoring diabetic retinopathy | |
| UA86387U (ru) | Способ оценки эффективности лечения больных с артериальной гипертензией, объединенной с метаболическим синдромом |